Cargando…
A Systematic Review and Mixed Treatment Comparison of Pharmaceutical Interventions for Multiple Sclerosis
BACKGROUND: Since 2010, 27 mixed-treatment comparisons (MTCs) of disease-modifying therapies (DMTs) for multiple sclerosis have been published. However, there has been continued evolution in the field of MTCs. Additionally, limitations in methodological approach and reporting transparency, even in t...
Autores principales: | Giovannoni, Gavin, Lang, Shona, Wolff, Robert, Duffy, Steven, Hyde, Robert, Kinter, Elizabeth, Wakeford, Craig, Sormani, Maria Pia, Kleijnen, Jos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7606402/ https://www.ncbi.nlm.nih.gov/pubmed/32989721 http://dx.doi.org/10.1007/s40120-020-00212-5 |
Ejemplares similares
-
Overview of Differences and Similarities of Published Mixed Treatment Comparisons on Pharmaceutical Interventions for Multiple Sclerosis
por: Pia Sormani, Maria, et al.
Publicado: (2020) -
Patient and physician preferences for multiple sclerosis treatments in Germany: A discrete-choice experiment study
por: Poulos, Christine, et al.
Publicado: (2020) -
Measuring the impact of multiple sclerosis: Enhancing the measurement performance of the Multiple Sclerosis Impact Scale (MSIS-29) using Rasch Measurement Theory (RMT)
por: Cleanthous, Sophie, et al.
Publicado: (2017) -
An Italian programme for COVID-19 infection in multiple sclerosis
por: Sormani, Maria Pia
Publicado: (2020) -
Reduced brain atrophy rates are associated with lower risk of disability progression in patients with relapsing multiple sclerosis treated with cladribine tablets
por: De Stefano, Nicola, et al.
Publicado: (2017)